Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $60,060 | 30 | 65.7% |
| Travel and Lodging | $15,791 | 32 | 17.3% |
| Consulting Fee | $9,820 | 4 | 10.7% |
| Food and Beverage | $5,717 | 200 | 6.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $81,542 | 145 | $0 (2024) |
| ViiV Healthcare Company | $8,884 | 65 | $0 (2024) |
| Janssen Biotech, Inc. | $526.85 | 30 | $0 (2019) |
| EMD Serono, Inc. | $223.91 | 17 | $0 (2019) |
| Merck Sharp & Dohme LLC | $210.97 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $321.21 | 22 | ViiV Healthcare Company ($257.95) |
| 2023 | $139.11 | 4 | Merck Sharp & Dohme LLC ($83.26) |
| 2020 | $7,874 | 8 | ViiV Healthcare Company ($7,845) |
| 2019 | $34,542 | 73 | Gilead Sciences, Inc. ($34,082) |
| 2018 | $23,429 | 70 | Gilead Sciences, Inc. ($22,862) |
| 2017 | $25,083 | 89 | Gilead Sciences Inc ($24,535) |
All Payment Transactions
266 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: HIV | ||||||
| 12/05/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $4.99 | General |
| Category: HIV | ||||||
| 10/17/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $9.84 | General |
| Category: HIV | ||||||
| 10/03/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $5.59 | General |
| Category: HIV | ||||||
| 08/16/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: HIV | ||||||
| 08/13/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $6.04 | General |
| Category: HIV | ||||||
| 08/01/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $4.56 | General |
| Category: HIV | ||||||
| 07/25/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: HIV | ||||||
| 07/11/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $9.42 | General |
| Category: HIV | ||||||
| 06/27/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: HIV | ||||||
| 06/06/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: HIV | ||||||
| 05/23/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: HIV | ||||||
| 05/23/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $7.08 | General |
| Category: HIV | ||||||
| 05/16/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: HIV | ||||||
| 04/26/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.84 | General |
| 04/25/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: HIV | ||||||
| 04/25/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $3.94 | General |
| Category: HIV | ||||||
| 04/04/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: HIV | ||||||
| 03/28/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: HIV | ||||||
| 03/22/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: HIV | ||||||
| 02/22/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/11/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/14/2023 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: HIV | ||||||
| 07/20/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: HIV | ||||||
| 03/31/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.29 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 50 | 78 | $57,942 | $7,770 |
| 2022 | 4 | 86 | 134 | $101,096 | $14,644 |
| 2021 | 5 | 158 | 227 | $152,188 | $23,872 |
| 2020 | 4 | 82 | 112 | $76,204 | $9,869 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 39 | 66 | $51,018 | $6,717 | 13.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 11 | 12 | $6,924 | $1,053 | 15.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 40 | 77 | $59,521 | $8,224 | 13.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 19 | $20,273 | $3,326 | 16.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 17 | 24 | $13,224 | $2,173 | 16.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 11 | 14 | $8,078 | $921.97 | 11.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 34 | 71 | $54,883 | $8,434 | 15.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 39 | 39 | $41,035 | $6,980 | 17.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 30 | 43 | $23,488 | $3,971 | 16.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 35 | 50 | $18,934 | $3,211 | 17.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 20 | 24 | $13,848 | $1,277 | 9.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 33 | 50 | $38,650 | $4,051 | 10.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 15 | 16 | $16,528 | $2,909 | 17.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 23 | 32 | $18,464 | $2,034 | 11.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 11 | 14 | $2,562 | $874.62 | 34.1% |
About Dr. Malcolm John, MD
Dr. Malcolm John, MD is a Internal Medicine healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003872870.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Malcolm John, MD has received a total of $91,388 in payments from pharmaceutical and medical device companies, with $321.21 received in 2024. These payments were reported across 266 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($60,060).
As a Medicare-enrolled provider, John has provided services to 376 Medicare beneficiaries, totaling 551 services with total Medicare billing of $56,155. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Infectious Disease
- Location San Francisco, CA
- Active Since 04/21/2006
- Last Updated 07/30/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1003872870
Products in Payments
- Truvada (Drug) $25,143
- Biktarvy (Drug) $24,312
- Genvoya (Drug) $11,738
- DOVATO (Drug) $8,191
- PREZCOBIX (Drug) $324.85
- TRIUMEQ (Drug) $307.19
- JULUCA (Drug) $253.20
- SEROSTIM (Biological) $198.72
- Symtuza (Drug) $188.65
- CABENUVA (Biological) $88.64
- PIFELTRO (Drug) $44.42
- ISENTRESS (Drug) $33.24
- Serostim (Biological) $25.19
- APRETUDE (Biological) $22.64
- TIVICAY (Drug) $20.90
- PREZISTA (Drug) $13.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in San Francisco
Dr. Fred Cohen, M.d, M.D
Internal Medicine — Payments: $1.6M
John Teerlink, M.d, M.D
Internal Medicine — Payments: $1.2M
Kenneth Binmoeller, Md, MD
Internal Medicine — Payments: $1.2M
Dr. Hope Rugo, Md, MD
Internal Medicine — Payments: $881,117
Dr. Steven Harris, M.d, M.D
Internal Medicine — Payments: $806,637
Dr. Kenneth Colley, Md, MD
Internal Medicine — Payments: $732,736